id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-288403-m6qe57he	Abbas, K. M.	Benefit-risk analysis of health benefits of routine childhood immunisation against the excess risk of SARS-CoV-2 infections during the Covid-19 pandemic in Africa	2020-05-26		.txt	text/plain	7098	317	45	First, we used previously reported country-specific child mortality impact estimates of childhood immunisation for diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, pneumococcal, rotavirus, measles, meningitis A, rubella, and yellow fever (DTP3, HepB3, Hib3, PCV3, RotaC, MCV1, MCV2, MenA, RCV, YFV) to approximate the future deaths averted before completing five years of age by routine childhood vaccination during a 6-month Covid-19 risk period without catch-up campaigns. Specifically, we conducted a benefit-risk analysis of vaccine-preventable deaths averted by sustaining routine childhood immunisation in comparison to excess Covid-19 deaths from SARS-CoV-2 infections acquired by visiting routine vaccination service delivery points. The central estimates for benefit-risk ratio at the household level show the child deaths averted by continuing the routine childhood immunisation programmes (1-dose MCV1, RCV1, MenA, YFV for 9-month-old children) per excess Covid-19 death caused by SARS-CoV2 infections acquired in the vaccination service delivery points.	./cache/cord-288403-m6qe57he.txt	./txt/cord-288403-m6qe57he.txt